![TCT-38: One-Year Outcomes after Implantation of XIENCE PRIME and XIENCE PRIME Long Lesion Stents in Patients with Coronary Artery Disease: Primary Endpoint Results of the SPIRIT PRIME Multicenter Clinical Trial | Journal TCT-38: One-Year Outcomes after Implantation of XIENCE PRIME and XIENCE PRIME Long Lesion Stents in Patients with Coronary Artery Disease: Primary Endpoint Results of the SPIRIT PRIME Multicenter Clinical Trial | Journal](https://www.jacc.org/cms/asset/7cb38d9c-3b73-48b4-9aec-b82782a41bd0/j.jacc.2011.10.043.fp.png)
TCT-38: One-Year Outcomes after Implantation of XIENCE PRIME and XIENCE PRIME Long Lesion Stents in Patients with Coronary Artery Disease: Primary Endpoint Results of the SPIRIT PRIME Multicenter Clinical Trial | Journal
![Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy - CHEST Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91ead806-40a3-4327-a4ee-8e6e29be43f6/gr1.jpg)
Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy - CHEST
![A Technology-Driven Solution for Optimized Statistical Analysis of Clinical Trial Biomarker Data - Quartz Bio A Technology-Driven Solution for Optimized Statistical Analysis of Clinical Trial Biomarker Data - Quartz Bio](https://www.quartz.bio/wp-content/uploads/2022/03/Biostatistics-Biomarker-Data-Article-2-Featured-Image.png)
A Technology-Driven Solution for Optimized Statistical Analysis of Clinical Trial Biomarker Data - Quartz Bio
![Ankush - Narsingi : Biostatistics bootcamp, clinical trials - CDISC, STDM, Adam, TLF, SAS programming - Base and advanced Ankush - Narsingi : Biostatistics bootcamp, clinical trials - CDISC, STDM, Adam, TLF, SAS programming - Base and advanced](https://www.superprof.co.in/images/teachers/teacher-home-biostatistics-bootcamp-clinical-trials-cdisc-stdm-adam-tlf-sas-programming-base-and-advanced.jpg)